Related Experiment Video
Updated: Jul 2, 2025
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Unraveling the Predictive Power: Placenta Growth Factor and Pregnancy-Associated Plasma Protein A in Pre-eclampsia
Aditi Singh Thakur1, Surekha Tayade1, Drashti Patel1
1Obstetrics and Gynecology, Jawaharlal Nehru Medical College, Wardha, IND.
Insights
This review explores placenta growth factor (PlGF) and pregnancy-associated plasma protein A (PAPP-A) in pre-eclampsia. Understanding these biomarkers is key for diagnosing and managing this hypertensive disorder.
Area of Science:
- Reproductive biology
- Maternal-fetal medicine
- Biochemistry
Background:
- Pre-eclampsia is a significant pregnancy-related hypertensive disorder impacting maternal and fetal health.
- It is characterized by placental dysfunction and angiogenic imbalance.
- Early diagnosis and effective management are crucial.
Purpose of the Study:
- To comprehensively review the roles of placenta growth factor (PlGF) and pregnancy-associated plasma protein A (PAPP-A) in pre-eclampsia.
- To explore their diagnostic potential and pathophysiological significance.
- To discuss therapeutic implications for future interventions.
Main Methods:
- Literature review synthesizing current research on PlGF and PAPP-A in pre-eclampsia.
- Analysis of biomarker dysregulation and its link to placental function.
- Examination of pathophysiological mechanisms including angiogenic imbalance.
Main Results:
- Altered levels of PlGF and PAPP-A are associated with pre-eclampsia.
- These biomarkers offer insights into the disorder's pathophysiology.
- Dysregulation contributes to placental dysfunction and angiogenic imbalance.
Conclusions:
- PlGF and PAPP-A are critical biomarkers for understanding pre-eclampsia.
- Targeting these factors presents potential therapeutic avenues.
- Further research is needed to improve maternal and infant outcomes.
Abstract:
This review provides a comprehensive exploration of the roles of placenta growth factor (PlGF) and pregnancy-associated plasma protein A (PAPP-A) in the context of pre-eclampsia, a pregnancy-related hypertensive disorder with significant implications for maternal and fetal health. The background elucidates the clinical significance of pre-eclampsia, highlighting its prevalence and impact. The review delves into the biological importance of PlGF and PAPP-A, emphasizing their critical roles in normal placental development and their dysregulation in pre-eclampsia. Notably, altered levels of these biomarkers emerge as potential diagnostic indicators, offering insights into the pathophysiology of the disorder. The exploration of pathophysiological mechanisms, including angiogenic imbalance and placental dysfunction, provides a nuanced understanding of pre-eclampsia's molecular landscape. The therapeutic implications of targeting PlGF and PAPP-A open avenues for future research, aiming at effective intervention strategies. The conclusion summarizes key findings, outlines implications for future research, and underscores the crucial role of PlGF and PAPP-A in understanding and managing pre-eclampsia, with the ultimate goal of improving outcomes for both mothers and infants.
More Related Videos
Related Concept Videos
01:13Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
01:07Teratogenicity
01:24Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...